Prevention of passively transferred experimental autoimmune myasthenia gravis by an in vitro selected RNA aptamer

FEBS Letters

Volumn 548, Issue 1-3, 2003, Pages 85-89

  Hwang, Byounghoon ^a   Han, Kyungsook ^b   Lee, Seong Wook ^a  

^a Dankook University   (South Korea)

^b Inha University   (South Korea)

Author keywords

Acetylcholine receptor; Autoantibody; Experimental autoimmune myasthenia gravis; In vitro selection; RNA aptamer

Indexed keywords

APTAMER; CHOLINERGIC RECEPTOR; MACROGOL; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 198; RNA APTAMER; UNCLASSIFIED DRUG; AUTOANTIBODY; MACROGOL DERIVATIVE; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IN VITRO STUDY; MYASTHENIA GRAVIS; NONHUMAN; PASSIVE TRANSPORT; PRIORITY JOURNAL; RAT; SYMPTOMATOLOGY; TREATMENT OUTCOME; ANIMAL; DOWN REGULATION; HUMAN; IMMUNOLOGY; LEWIS RAT; METABOLISM;

ANIMALIA;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; DOWN-REGULATION; HUMANS; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; POLYETHYLENE GLYCOLS; RATS; RATS, INBRED LEW; RECEPTORS, CHOLINERGIC; RNA;

EID: 0042737486     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(03)00745-2     Document Type: Article

References (27)

1. Drachman D.B. New Engl. J. Med. 330:1994;1797-1810.
2. Lindstrom J., Shelton D., Fugii Y. Adv. Immunol. 42:1988;233-284.
3. Tzartos S.J., Rand D.E., Einarson B.L., Lindstrom J.M. J. Biol. Chem. 256:1981;8635-8645.
4. Tzartos S.J., Seybold M.E., Lindstrom J.M. Proc. Natl. Acad. Sci. USA. 79:1982;188-192.
5. Araga S., Galin F.S., Kishimoto M., Adachi A., Blalock J.E. J. Immunol. 157:1996;386-392.
6. Papanastasiou D., Poulas K., Kokla A., Tzartos S.J. J. Neuroimmunol. 104:2000;14-132.
7. Venkatesh N., Im S.-H., Balass M., Fuchs S., Katchalski-Katzir E. Proc. Natl. Acad. Sci. USA. 97:2000;761-766.
8. Tuerk C., Gold L. Science. 249:1990;505-510.
9. Elligton A.D., Szostak J.W. Nature. 346:1990;818-822.
10. Sullenger B.A., Gilboa E. Nature. 418:2002;252-258.
11. Gold, L., Allen, P., Binkley, J., Brown, D., Schneider, D., Eddy, S. R., Tuerk, C., Green, L., Macdougal, S. and Tasset, D. (1993) in: The RNA World (Gestelend, R.F. and Atkins, J.F. Eds.), pp. 497-510, Cold Spring Harbor Press, Cold Spring Harbor, NY.
12. Tucker C.E., Chen L.S., Judkins M.B., Farmer J.A., Gill S.C., Drolet D.W. J. Chromatogr. B Biomed. Sci. Appl. 732:1999;203-212.
13. Watson S.R., Chang Y.F., O'Connell D., Weigand L., Ringquist S., Parma D.H. Antisense Nucleic Acid Drug Dev. 10:2000;63-75.
14. Lee S.-W., Sullenger B. Nat. Biotechnol. 15:1997;41-45.
15. Seo H.-S., Lee S.-W. J. Microbiol. Biotechnol. 10:2000;707-713.
16. Hwang B., Lee S.-W. Biochem. Biophys. Res. Commun. 290:2002;656-662.
17. Stratton M.R., Darling J., Pikington G.J., Lantos P.L., Reeves B.R., Cooper C.S. Carcinogenesis. 10:1989;899-905.
18. Luther M.A., Schoepfer R., Whiting P., Casey B., Blatt Y., Montal M.S., Montal M., Lindstrom J. J. Neurosci. 9:1989;1082-1096.
19. Fizwater T., Polisky B. Methods Enzymol. 267:1996;275-301.
20. Ostendorf T., Kunter U., Eitner F., Loos A., Regele H., Kerjaschki D., Henninger D.D., Janjic N., Floege J. J. Clin. Invest. 104:1999;913-923.
21. White R., Rusconi C., Scardino E., Wolberg A., Lawson J., Hoffman M., Sullenger B. Mol. Ther. 4:2001;567-573.
22. Souroujon M.C., Pizzighella S., Mochly-Rosen D., Fuchs S. J. Neuroimmunol. 8:1985;159-166.
23. Sophianos D., Tzartos S. J. Autoimmun. 2:1989;777-789.
24. Saedi M.S., Anand R., Conroy W.G., Lindstrom J.M. FEBS Lett. 267:1990;55-59.
25. Gold L., Polisky B., Uhlenbeck O.C., Yarus M. Annu. Rev. Biochem. 64:1995;763-795.
26. Vincent A., Whiting P.J., Schluep M., Heidenreich F., Lang B., Roberts A., Willcox N., Newson-Davis J. Ann. NY Acad. Sci. 505:1987;106-120.
27. Jaeger J., Turner D., Zuker M. Proc. Natl. Acad. Sci. USA. 86:1989;7706-7710.